Abstract
Purpose
The aim of this study is to investigate guideline application and colonoscopy findings in real-life practice in acromegaly.
Methods
We conducted a retrospective observational non-interventional and cross-sectional analysis on 146 patients with acromegaly (ACRO) referred to our clinic. We evaluated colonoscopy data, focusing on the correlation between colonoscopy findings and hormonal/metabolic values.
Results
The total number of colonoscopies performed in ACRO patients increased from 6 in the period 1990–1994 to 57 in the period 2010–2014. Colonoscopy procedures were performed according to guidelines in 25% of ACRO patients at diagnosis, 51% at follow-up and 11% globally (both at diagnosis and follow-up). Among the 146 ACRO patients, 68% were subjected to at least one colonoscopy and in 32% of the cases a polyp was detected during the procedure. The presence of polyps was significantly associated with mean levels of growth hormone (GH), insulin-like growth factor 1 (IGF-1), fasting glucose and insulin levels (p < 0.05). Polyps were detected in 48% of untreated patients and in 26% of patients under treatment for acromegaly (p = 0.04). The general risk of polyps and adenomatous polyps in ACRO patients was higher compared to the control population of Veneto Region, Italy (odds ratio 1.33 and 1.16, respectively). No cancerous polyps were detected in our analysis.
Conclusion
In real-life practice, adherence to ACRO colonoscopy clinical guidelines was lower than expected. Among patients who underwent colonoscopy, the prevalence of colon polyps was higher for ACRO patients, suggesting the need for new strategies to ensure adherence to colonoscopy guidelines.
Similar content being viewed by others
References
Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Investig 119:3189–3202
Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558–2573
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152
Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9:41–58
Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G (2008) Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 14:3484–3489
Matano Y, Okada T, Suzuki A, Yoneda T, Takeda Y, Mabuchi H (2005) Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels. Am J Gastroenterol 100:1154–1160
Renehan AG, Bhaskar P, Painter JE, O’Dwyer ST, Haboubi N, Varma J (2000) The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3417–3424
Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16:294–302
Jenkins PJ, Fairclough PD, British Society for Gastroenterology, & Association of Coloproctology for Great Britain and Ireland (2002) Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut 51(Suppl 5):V13–V14
Ezzat S, Serri O, Chik CL, Johnson MD, Beauregard H, Marcovitz S (2006) Canadian consensus guidelines for the diagnosis and management of acromegaly. Clin Investig Med 29:29–39
Cozzi R, Baldelli R, Colao A, Lasio G, Zini M, Attanasio R (2009) AME position statement on clinical management of acromegaly. J Endocrinol Invest 32:2–25
Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK (2011) American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly–2011 update. Endocr Pract 17:1–44
Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A (2002) Guidelines for acromegaly management. J Clin Endocrinol Metab 87:4054–4058
Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA (2003) Diagnosis and treatment of acromegaly complications. J Endocrinol Invest 26:1242–1247
Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R (2005) Consensus statement: medical management of acromegaly. Eur J Endocrinol 153:737–740
Loberg M, Kalager M, Holme O et al (2014) Long term colorectal.cancer mortality after adenoma removal. N Engl J Med 371:799–807
Buda A, De Bona M, Dotti I, Piselli P, Zabeo E, Barbazza R, Bellumat A, Valiante F, Nardon E, Probert CS, Pignatelli M, Stanta G, Sturniolo GC, De Boni M (2012) Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol 3:6
Dworakowska D, Gueorguiev M, Kelly P, Monson JP, Besser GM, Chew SL (2010) Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines. Eur J Endocrinol 163:21–28
Renehan AG, Painter JE, Bell GD, Rowland RS, O’Dwyer ST, Shalet SM (2005) Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clin Endocrinol 62:323–330
Jenkins PJ, Frajese V, Jones AM, Camacho-Hubner C, Lowe DG, Fairclough PD (2000) Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85:3218–3221
Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, Vitale G (2005) Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in italy. J Clin Endocrinol Metab 90:84–90
Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86:2935–2941
Bogazzi F, Cosci C, Sardella C, Costa A, Manetti L, Gasperi M (2006) Identification of acromegalic patients at risk of developing colonic adenomas. J Clin Endocrinol Metab 91:1351–1356
Colao A, Pivonello R, Auriemma RS, Galdiero M, Ferone D, Minuto F (2007) The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. J Clin Endocrinol Metab 92:3854–3860
Yamamoto M, Fukuoka H, Iguchi G, Matsumoto R, Takahashi M, Nishizawa H (2014) The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study. Pituitary 18(3):343–351
Bhansali A, Kochhar R, Chawla YK, Reddy S, Dash RJ (2004) Prevalence of colonic polyps is not increased in patients with acromegaly: analysis of 60 patients from india. J Gastroenterol Hepatol 19:266–269
Larijani B, Aliannejad R, Khaleghnejad-Tabari N, Baradar-Jalili R, Ansari R, Tavangar SM (2007) The prevalence of polyp in colon of patients with acromegaly. Arch Iran Med 10:236–238
Klein I, Parveen G, Gavaler JS, Vanthiel DH (1982) Colonic polyps in patients with acromegaly. Ann Intern Med 97:27–30
Jenkins PJ (2004) Acromegaly and cancer. Horm Res 62(Suppl 1):108–115
Acknowledgements
Editorial assistance for the preparation of this manuscript was provided by Ambra Corti and Luca Giacomelli, PhD, on behalf of Content Ed Net; this assistance was funded by Novartis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr Maffei has received unrestricted grants from Novartis, Pfizer and Ipsen and is member of Novartis, Italfarmaco, Pfizer and Ipsen advisory board. No financial support was provided for this study.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Parolin, M., Dassie, F., Russo, L. et al. Guidelines versus real life practice: the case of colonoscopy in acromegaly. Pituitary 21, 16–24 (2018). https://doi.org/10.1007/s11102-017-0841-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-017-0841-7